This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Dermatologic Disorders  • Quality of Care  • Evidence-Based Medicine  • Women's Health  • Papillomavirus, Human  • Gynecology  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Mark H. Stoler, MD

JAMA. 2002;287:2140-2141.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In women's health, a remarkable convergence of events in 2001 has produced new information and direction to foster systematic improvement in cervical cancer screening. The Atypical Squamous Cells of Undetermined Significance–Low-grade Squamous Intraepithelial Lesion (ASCUS-LSIL) Triage Study (ALTS), which is sponsored by the National Cancer Institute, has published several articles presenting long-awaited data regarding the utility of human papillomavirus (HPV) testing in the context of the most common forms of cytological abnormality.^1-4 These data supported the effort to revise the Bethesda System terminology used for reporting results of cervical cytology screening. Both the new Bethesda terminology and the ALTS data directly influenced management guidelines produced by the American Society of Colposcopy and Cervical Pathology (ASCCP)–sponsored consensus conference.

The efforts of the Bethesda System group and the ASCCP are all the more noteworthy because they used the World Wide Web as a platform for long-term and broad-based . . . [Full Text of this Article]

Author Affiliation: Robert E. Fechner Laboratory of Surgical Pathology, University of Virginia Health System, Charlottesville.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology
, , , , , , , , , , , and
JAMA. ;287():2114-2119.
FULL TEXT  

2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
, , , , , and
JAMA. ;287():2120-2129.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
Arbyn et al.
JNCI J Natl Cancer Inst 2004;96:280-293.
ABSTRACT | FULL TEXT  

New Bethesda Terminology and Management Guidelines for Pap Smear Findings
Journal Watch Dermatology 2002;2002:10-10.
FULL TEXT  

New Bethesda Terminology and Management Guidelines for Pap Smear Findings
JWatch General 2002;2002:1-1.
FULL TEXT